NCT07085572
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07085572
Title Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer (INTERVAL)
Acronym INTERVAL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.